Vitolo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.875
AS - Asia 7.253
EU - Europa 4.063
SA - Sud America 1.125
OC - Oceania 262
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.728
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.636
SG - Singapore 2.233
CN - Cina 2.007
IT - Italia 1.445
HK - Hong Kong 991
BR - Brasile 903
VN - Vietnam 674
GB - Regno Unito 555
FI - Finlandia 449
SE - Svezia 364
BD - Bangladesh 313
DE - Germania 311
KR - Corea 310
AU - Australia 255
RU - Federazione Russa 246
FR - Francia 190
ID - Indonesia 130
CA - Canada 122
IN - India 116
AR - Argentina 86
NL - Olanda 73
MX - Messico 66
BG - Bulgaria 60
IQ - Iraq 58
JP - Giappone 55
TR - Turchia 55
AE - Emirati Arabi Uniti 52
PL - Polonia 45
ZA - Sudafrica 45
AT - Austria 43
ES - Italia 41
PK - Pakistan 41
UA - Ucraina 40
LT - Lituania 35
CO - Colombia 32
EC - Ecuador 32
UZ - Uzbekistan 30
IE - Irlanda 29
MA - Marocco 25
MY - Malesia 23
VE - Venezuela 22
KE - Kenya 20
EG - Egitto 18
SA - Arabia Saudita 18
AZ - Azerbaigian 16
CL - Cile 16
RS - Serbia 16
TH - Thailandia 16
BE - Belgio 13
CH - Svizzera 13
CZ - Repubblica Ceca 13
JO - Giordania 13
NP - Nepal 12
OM - Oman 12
PH - Filippine 12
RO - Romania 12
TN - Tunisia 12
TW - Taiwan 12
AL - Albania 11
BO - Bolivia 10
PY - Paraguay 10
DZ - Algeria 9
KZ - Kazakistan 9
PE - Perù 8
TT - Trinidad e Tobago 8
IL - Israele 7
NZ - Nuova Zelanda 7
GT - Guatemala 6
HU - Ungheria 6
SV - El Salvador 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
CU - Cuba 5
DO - Repubblica Dominicana 5
GE - Georgia 5
KG - Kirghizistan 5
LU - Lussemburgo 5
LV - Lettonia 5
NG - Nigeria 5
PT - Portogallo 5
UY - Uruguay 5
CY - Cipro 4
EE - Estonia 4
HR - Croazia 4
IR - Iran 4
JM - Giamaica 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
LB - Libano 3
LK - Sri Lanka 3
MT - Malta 3
NO - Norvegia 3
SI - Slovenia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
Totale 21.697
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.486
Singapore 1.402
Ashburn 1.091
Hong Kong 981
Hefei 891
San Jose 721
Chandler 427
Fairfield 395
Helsinki 390
London 319
Seoul 304
Nyköping 283
Beijing 277
The Dalles 256
Council Bluffs 243
New York 236
Ho Chi Minh City 217
Los Angeles 177
Houston 175
Woodbridge 169
Perth 167
Seattle 159
Milan 157
Hanoi 151
Wilmington 140
Chicago 128
Cambridge 127
Bologna 124
Buffalo 108
San Diego 106
Jakarta 103
Rome 103
Dallas 101
Munich 97
São Paulo 93
Modena 91
Lauterbourg 79
Shanghai 78
Princeton 69
Ann Arbor 67
Moscow 63
Southend 63
Sofia 56
Salt Lake City 53
Kent 50
Da Nang 43
Sydney 42
Toronto 42
Frankfurt am Main 41
Boardman 40
Tokyo 39
Orem 37
Lappeenranta 36
Montreal 36
Johannesburg 34
Columbus 32
Nuremberg 30
Dublin 28
Haiphong 28
Tashkent 28
Amsterdam 27
Mexico City 27
Redondo Beach 27
Denver 26
Kilburn 26
Naples 26
Atlanta 25
Rio de Janeiro 25
Warsaw 25
Guangzhou 24
Parma 23
Chennai 22
Reggio Emilia 22
Turku 22
Schiffdorf 21
Turin 21
Baghdad 20
Elk Grove Village 20
Biên Hòa 19
Miami 19
Phoenix 19
Stockholm 19
Tampa 19
Vienna 19
Jacksonville 18
Memphis 18
Belo Horizonte 17
Boston 17
Brooklyn 17
Campinas 17
Paris 17
Portsmouth 17
Dubai 16
Düsseldorf 15
Florence 15
Nairobi 15
Perugia 15
Ankara 14
Brasília 14
Charlotte 14
Totale 14.308
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 501
Radar-Based Monitoring of Vital Signs: A Tutorial Overview 336
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes 309
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 303
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 293
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 276
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 254
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 254
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport 247
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 245
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 243
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 234
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 232
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 218
Progression of Atrial Fibrillation after Cryoablation 217
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 217
Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes 217
Atrial fibrillation burden: Stepping beyond the categorical characterization 214
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation 206
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 202
What do we do about atrial high rate episodes? 201
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 201
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years 200
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 199
Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation 199
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 197
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 194
Single-lead VDD pacing: a literature review on short-term and long-term performance 193
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology 193
Atrial fibrillation in patients with cardiac implantable electronic devices: New perspectives with important clinical implications 189
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation 188
Female sex and stroke in atrial fibrillation: an intriguing relationship 188
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 187
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis 187
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 187
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 187
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 186
Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases 184
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis 183
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 182
Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications 181
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 177
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 175
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 175
Permanent Atrial Fibrillation as the Terminal Stage of a Chronic Disease: Palliative Care Needs to be Considered in Selected Patients with Markedly Impaired Quality of Life 174
Atrial Fibrillation and Other Cardiovascular Factors and the Risk of Dementia: An Italian Case–Control Study 173
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 173
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes 171
Ibrutinib and Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia: focus on atrial fibrillation and ventricular tachyarrhythmias/sudden cardiac death 170
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 170
Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes 170
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 167
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 163
Atrial fibrillation in pneumonia: what clinical implications at long-term? 162
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 161
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 161
Grey zones in the practice of permanent cardiac pacing: The case of preventive pacing for improving rhythm control in atrial fibrillation 161
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 159
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 158
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients 157
Burden of disease and costs of infections associated with cardiac implantable electronic devices 156
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 155
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 155
Biomarkers in atrial fibrillation: A constant search for simplicity, practicality, and cost-effectiveness 154
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 153
Anthropometric parameters and radiation doses during percutaneous coronary procedures 152
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: A systematic review and meta-analysis of 81,462 patients 152
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 152
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 151
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 150
COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease 150
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 149
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 146
Clinical decisions for appropriate management of patients with atrial fibrillation 145
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe 144
Cardiac resynchronization therapy: Need to synchronize patients and device longevities with comorbidities 144
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 144
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 143
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry 141
GESTIONE CLINICA, COMORBIDITÀ ED EVENTI AVVERSI ASSOCIATI IN PAZIENTI CON FIBRILLAZIONE ATRIALE: ANALISI DA UNO STUDIO DI COORTE EUROPEO SU OLTRE 11.000 PAZIENTI 140
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 140
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 136
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores 135
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 135
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort 133
Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry 132
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry 132
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 132
Cardiomyopathy associated with long-term right ventricular pacing: an intriguing clinical issue 130
Red cell distribution width and patient outcome in cardiovascular disease: A ‘’real-world” analysis 129
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 129
How did COVID-19 affect medical and cardiology journals? A pandemic in literature 128
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 127
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation 126
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 125
The 12-lead ECG: A continuous reference for the cardiologist 125
Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation 125
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 124
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry 124
Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome 123
Totale 17.967
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 0 0 0 0 0 0 0 0 0 71
2021/20221.164 72 80 20 38 39 102 30 57 128 99 244 255
2022/20231.454 155 154 119 69 125 175 49 149 206 44 130 79
2023/20241.648 52 86 107 170 283 238 123 213 38 51 87 200
2024/20255.807 131 91 299 364 991 780 546 346 564 414 618 663
2025/202610.711 744 437 901 1.119 1.060 600 1.624 573 1.180 938 890 645
Totale 21.930